Trust in AstraZeneca’s Covid jab falls across the EU amid blood clot fears 

Trust in AstraZeneca’s Covid jab falls across the EU after leaders halted the rollout last week amid blood clot fears Confidence in AstraZeneca’s Covid-19 vaccine has plunged across Europe European leaders paused rollout of jab last week over fears it caused blood clots European Medicines Agency said vaccine was not associated with clotting risk By … Read more

15M in US could be vaccinated if it approved AstraZeneca’s shot

Nearly 15 million more Americans could be fully vaccinated against COVID-19, getting back to work and seeing their families – but millions vials of AstraZeneca‘s vaccine are sitting unused in a manufacturing plant.  That’s because the shot – which, along with its highly successful delayed dosing program – that has helped the UK speed ahead … Read more

Why is Britain getting doses of AstraZeneca’s Covid vaccine from India?

The vaccine roll-out was plunged into its first real crisis last night as the NHS revealed a major four-week fall in supply, meaning millions of people under 50 now face a much longer wait for their first vaccine appointment than many had hoped. The jabs shortage was triggered by delays to a shipment of 5million … Read more

AstraZeneca’s Covid vaccine not linked to Italian teacher’s death, autopsy finds

An Italian music teacher who passed away a day after getting AstraZeneca’s Covid vaccine likely died from a sudden heart problem that was not linked to the shot, according to the initial findings of an autopsy.  Sandro Tognatti, 57, who died in the town of Biella on Sunday, had no evidence of blood clots in … Read more

Coronavirus: Pfizer’s Covid vaccine is linked to MORE blood clots than AstraZeneca’s in the UK

Pfizer‘s Covid vaccine has been linked to more blood clots than AstraZeneca‘s in reports from the UK, statistics show as Europe reels from a ‘baffling’ decision to snub the jab.  Thirteen countries on the continent have now turned their backs on the Oxford University Covid vaccine after regulators said they were investigating links to deadly … Read more

U.S. data for AstraZeneca’s COVID-19 vaccine clinical trial is under review by independent advisors

Long-awaited results from AstraZeneca Plc’s U.S coronavirus vaccine trial are currently being reviewed by independent advisors to determine whether the shot is safe and effective. Dr Francis Collins, director of the National Institutes of Health (NIH), said the drug company and its partner, the University of Oxford, completed enrollment of 30,000 participants earlier this year.  … Read more

AstraZeneca’s Covid jab is NOT linked to blood clots, top scientists say

There is ‘no signal’ that the Oxford and AstraZeneca Covid vaccine is causing blood clots, scientists have said in response to scaremongering from European officials.  At least five EU countries and Thailand have stopped using the jab on members of the public after reports of people developing clots after having it in some nations. But regulators … Read more

UK could miss out on 3.5m doses between now and February and rely totally on AstraZeneca’s plan

What would happen if the EU forced Pfizer to stop delivering Covid vaccines? UK could miss out on 3.5m doses between now and February and rely totally on AstraZeneca’s plan to hit 2m per week by Monday Eurocrats proposed plans to stop vaccine exports could cut Britain’s supplies  Pfizer – which manufactures doses in Belgium … Read more

Doctor slams FDA for not approving AstraZeneca’s coronavirus vaccine

A doctor has slammed the U.S. Food and Drug Administration (FDA) for not approving AstraZeneca-University of Oxford’s coronavirus vaccine. On Wednesday, Great Britain became the fist country in the world to grant authorization to the COVID-19 jab. The vaccine holds great appeal because it’s inexpensive – costing $3 to $4 per dose – and can … Read more

MARKET REPORT: Astrazeneca’s game-changer jab given rubber stamp

Drugs giant Astrazeneca reached a crucial milestone yesterday after regulators approved its Covid vaccine for use in the UK. The second-largest company on the FTSE 100 has spent months developing the jab with Oxford University. Around 530,000 doses will be available from next week, turbocharging the number of vaccines that can be rolled out in … Read more